Third quarter GAAP and adjusted revenue increased 1% to
EBITDA increased 1% to
"We are very pleased with the continued strong execution by our business leaders this quarter," said
"We successfully deployed
Increasing 2020 Guidance
The Company now expects full year adjusted
For the fourth quarter of 2020, the Company expects adjusted
The Company’s guidance excludes the impact of unannounced future acquisitions or divestitures.
Conference Call to be Held at
A conference call to discuss these results has been scheduled for
Use of Non-GAAP Financial Information
The Company supplements its consolidated financial statements presented on a GAAP basis with certain non-GAAP financial information to provide investors with greater insight, increase transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making. Reconciliation of non-GAAP measures to their most directly comparable GAAP measures are included in the accompanying financial schedules or tables. The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures prepared in accordance with GAAP, and the financial results prepared in accordance with GAAP and reconciliations from these results should be carefully evaluated.
Table 1: Adjusted Revenue, Gross Profit and EBITDA Reconciliation ($M) | |||||||||||
Q3 2019 | Q3 2020 | V % | |||||||||
Adjusted Revenue Reconciliation | |||||||||||
GAAP Revenue | $ | 1,354 | $ | 1,366 | 1 | % | |||||
Purchase accounting adjustment to acquired deferred revenue | 3 | 3 | A | ||||||||
Adjusted Revenue | $ | 1,358 | $ | 1,369 | 1 | % | |||||
Components of Adjusted Revenue Growth | |||||||||||
Organic | (3 | ) | % | ||||||||
Acquisitions/Divestitures | 3 | % | |||||||||
Foreign Exchange | — | % | |||||||||
Rounding | 1 | % | |||||||||
Total Adjusted Revenue Growth | 1 | % | |||||||||
Adjusted Gross Profit Reconciliation | |||||||||||
GAAP Gross Profit | $ | 874 | $ | 876 | |||||||
Purchase accounting adjustment to acquired deferred revenue | 3 | 3 | A | ||||||||
Adjusted Gross Profit | $ | 877 | $ | 879 | — | % | |||||
GAAP Gross Margin | 64.5 | % | 64.1 | % | (40 bps) | ||||||
Adjusted Gross Margin | 64.6 | % | 64.2 | % | (40 bps) | ||||||
Adjusted EBITDA Reconciliation | |||||||||||
GAAP Net Earnings | $ | 278 | $ | 234 | |||||||
Taxes | 60 | 69 | |||||||||
Interest Expense | 49 | 62 | |||||||||
Depreciation | 12 | 13 | |||||||||
Amortization | 94 | 117 | |||||||||
EBITDA | $ | 493 | $ | 495 | — | % | |||||
Purchase accounting adjustment to acquired deferred revenue and commission expense | 3 | 3 | A | ||||||||
Transaction-related expenses for completed acquisitions and divestiture | 2 | 3 | B | ||||||||
Adjusted EBITDA | $ | 498 | $ | 501 | 1 | % | |||||
% of Adjusted Revenue | 36.7 | % | 36.6 | % | (10 bps) |
Table 2: Adjusted DEPS Reconciliation C | ||||||||||||
Q3 2019 | Q3 2020 | V % | ||||||||||
GAAP | $ | 2.64 | $ | 2.21 | (16 | ) | % | |||||
Purchase accounting adjustment to acquired deferred revenue and commission expense | 0.02 | 0.02 | A | |||||||||
Transaction-related expenses for completed acquisitions and divestiture | 0.02 | 0.08 | B | |||||||||
Amortization of acquisition-related intangible assets D | 0.70 | 0.86 | ||||||||||
Adjustment to income tax expense related to the gain on sale of Scientific Imaging businesses | 0.01 | — | ||||||||||
Adjustment to previously recognized deferred tax expense related to new deal structure for divestiture of | (0.10 | ) | — | |||||||||
Adjusted | $ | 3.29 | $ | 3.17 | (4 | ) | % |
Table 3: Adjusted Cash Flow Reconciliation ($M) | |||||||||||||
Q3 2019 | Q3 2020 | V % | |||||||||||
Operating Cash Flow | $ | 404 | $ | 138 | (66 | ) | % | ||||||
Cash taxes paid on sale of | — | 192 | |||||||||||
Deferred tax payments E | — | 124 | |||||||||||
Adjusted Operating Cash Flow | 404 | 454 | 12 | % | |||||||||
Capital Expenditures | (14 | ) | (8 | ) | |||||||||
Capitalized Software Expenditures | (3 | ) | (5 | ) | |||||||||
Adjusted Free Cash Flow | $ | 387 | $ | 442 | 14 | % |
Table 4: Forecasted Adjusted DEPS Reconciliation C | |||||||||||||||
Q4 2020 | FY 2020 | ||||||||||||||
Low End | High End | Low End | High End | ||||||||||||
GAAP | $ | 2.36 | $ | 2.46 | $ | 8.92 | $ | 9.02 | |||||||
Purchase accounting adjustment to acquired deferred revenue and commission expense A | 0.03 | 0.03 | 0.07 | 0.07 | |||||||||||
Restructuring charge associated with certain Process Technologies businesses | — | — | 0.10 | 0.10 | |||||||||||
Transaction-related expenses for completed acquisitions B | — | — | 0.09 | 0.09 | |||||||||||
Amortization of acquisition-related intangible assets D | 1.00 | 1.00 | 3.37 | 3.37 | |||||||||||
Adjusted | $ | 3.39 | $ | 3.49 | $ | 12.55 | $ | 12.65 |
A. | 2020 actual results and forecast of estimated acquisition-related fair value adjustments to deferred revenue and commission expense related to the acquisitions of Foundry, iPipeline, and | |||||||||||||||||
Q3 2019A | Q3 2020A | Q4 2020E | FY 2020E | |||||||||||||||
Pretax | $ | 3 | $ | 3 | $ | 3 | $ | 10 | ||||||||||
After-tax | $ | 2 | $ | 2 | $ | 3 | $ | 8 | ||||||||||
Per Share | $ | 0.02 | $ | 0.02 | $ | 0.03 | $ | 0.07 | ||||||||||
B. | Transaction-related expenses for the | |||||||||||||||||
C. | All Q3'19 and 2020 adjustments taxed at 21%. | |||||||||||||||||
D. | Actual results and forecast of estimated amortization of acquisition-related intangible assets ($M, except per share data); for comparison purposes, prior period amounts are also shown below. Tax rate of 21% applied to amortization. | |||||||||||||||||
Q3 2019A | Q3 2020A | Q4 2020E | FY 2020E | |||||||||||||||
Pretax | $ | 93 | $ | 116 | $ | 134 | $ | 450 | ||||||||||
After-tax | $ | 73 | $ | 91 | $ | 106 | $ | 356 | ||||||||||
Per share | $ | 0.70 | $ | 0.86 | $ | 1.00 | $ | 3.37 | ||||||||||
E. |
Note: Numbers may not foot due to rounding.
About
The information provided in this press release contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements may include, among others, statements regarding operating results, the success of our internal operating plans, the prospects for newly acquired businesses to be integrated and contribute to future growth, and profit and cash flow expectations. Forward-looking statements may be indicated by words or phrases such as "anticipate," "estimate," "plans," "expects," "projects," "should," "will," "believes," "intends" and similar words and phrases. These statements reflect management's current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those contained in any forward-looking statement. Such risks and uncertainties include the effects of the COVID-19 pandemic on our business, operations, financial results and liquidity, including the duration and magnitude of such effects, which will depend on numerous evolving factors which we cannot accurately predict or assess, including: the duration and scope of the pandemic; the negative impact on global and regional markets, economies and economic activity; actions governments, businesses and individuals take in response to the pandemic; the effects of the pandemic, including all of the foregoing, on our customers, suppliers, and business partners, and how quickly economies and demand for our products and services recover after the pandemic subsides. Such risks and uncertainties also include our ability to identify and complete acquisitions consistent with our business strategies, integrate acquisitions that have been completed, realize expected benefits and synergies from, and manage other risks associated with, the newly acquired businesses. We also face other general risks, including our ability to realize cost savings from our operating initiatives, general economic conditions and the conditions of the specific markets in which we operate, changes in foreign exchange rates, difficulties associated with exports, risks associated with our international operations, cybersecurity and data privacy risks, risks related to political instability, armed hostilities, incidents of terrorism, public health crisis (such as the COVID-19 pandemic) or natural disasters, increased product liability and insurance costs, increased warranty exposure, future competition, changes in the supply of, or price for, parts and components, environmental compliance costs and liabilities, risks and cost associated with litigation, including asbestos related litigation, potential write-offs of our substantial intangible assets, and risks associated with obtaining governmental approvals and maintaining regulatory compliance for new and existing products. Important risks may be discussed in current and subsequent filings with the
Condensed Consolidated Balance Sheets (unaudited) | |||||||||
(Amounts in millions) | |||||||||
ASSETS: | |||||||||
Cash and cash equivalents | $ | 302.1 | $ | 709.7 | |||||
Accounts receivable, net | 773.4 | 791.6 | |||||||
Inventories, net | 214.9 | 198.6 | |||||||
Income taxes receivable | 43.1 | 18.5 | |||||||
Unbilled receivables | 249.9 | 183.5 | |||||||
Other current assets | 122.8 | 97.6 | |||||||
Total current assets | 1,706.2 | 1,999.5 | |||||||
Property, plant and equipment, net | 146.6 | 139.9 | |||||||
14,158.6 | 10,815.4 | ||||||||
Other intangible assets, net | 7,122.5 | 4,667.7 | |||||||
Deferred taxes | 95.1 | 95.6 | |||||||
Other assets | 423.0 | 390.8 | |||||||
Total assets | $ | 23,652.0 | $ | 18,108.9 | |||||
LIABILITIES AND STOCKHOLDERS' EQUITY: | |||||||||
Accounts payable | $ | 173.1 | $ | 162.0 | |||||
Accrued compensation | 251.5 | 240.1 | |||||||
Deferred revenue | 868.1 | 831.8 | |||||||
Other accrued liabilities | 409.3 | 346.2 | |||||||
Income taxes payable | 35.1 | 215.1 | |||||||
Current portion of long-term debt, net | 602.8 | 602.2 | |||||||
Total current liabilities | 2,339.9 | 2,397.4 | |||||||
Long-term debt, net of current portion | 9,101.2 | 4,673.1 | |||||||
Deferred taxes | 1,563.9 | 1,108.1 | |||||||
Other liabilities | 486.1 | 438.4 | |||||||
Total liabilities | 13,491.1 | 8,617.0 | |||||||
Common stock | 1.1 | 1.1 | |||||||
Additional paid-in capital | 2,069.9 | 1,903.9 | |||||||
Retained earnings | 8,349.4 | 7,818.0 | |||||||
Accumulated other comprehensive loss | (241.4 | ) | (212.8 | ) | |||||
(18.1 | ) | (18.3 | ) | ||||||
Total stockholders' equity | 10,160.9 | 9,491.9 | |||||||
Total liabilities and stockholders' equity | $ | 23,652.0 | $ | 18,108.9 |
Condensed Consolidated Statements of Earnings (unaudited) | ||||||||||||||||||
(Amounts in millions, except per share data) | ||||||||||||||||||
Three months ended | Nine months ended | |||||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||||
Net revenues | $ | 1,366.1 | $ | 1,354.5 | $ | 4,021.8 | $ | 3,972.0 | ||||||||||
Cost of sales | 490.2 | 480.9 | 1,445.4 | 1,437.8 | ||||||||||||||
Gross profit | 875.9 | 873.6 | 2,576.4 | 2,534.2 | ||||||||||||||
Selling, general and administrative expenses | 508.3 | 488.4 | 1,526.0 | 1,434.2 | ||||||||||||||
Income from operations | 367.6 | 385.2 | 1,050.4 | 1,100.0 | ||||||||||||||
Interest expense, net | 62.3 | 48.8 | 155.2 | 137.6 | ||||||||||||||
Other income (expense), net | (2.2 | ) | 1.5 | (3.4 | ) | (2.6 | ) | |||||||||||
Gain on disposal of business | — | — | — | 119.6 | ||||||||||||||
Earnings before income taxes | 303.1 | 337.9 | 891.8 | 1,079.4 | ||||||||||||||
Income taxes | 68.7 | 60.4 | 197.9 | 182.6 | ||||||||||||||
Net earnings | $ | 234.4 | $ | 277.5 | $ | 693.9 | $ | 896.8 | ||||||||||
Net earnings per share: | ||||||||||||||||||
Basic | $ | 2.24 | $ | 2.67 | $ | 6.64 | $ | 8.64 | ||||||||||
Diluted | $ | 2.21 | $ | 2.64 | $ | 6.57 | $ | 8.54 | ||||||||||
Weighted average common shares outstanding: | ||||||||||||||||||
Basic | 104.7 | 104.0 | 104.5 | 103.8 | ||||||||||||||
Diluted | 105.9 | 105.2 | 105.6 | 105.0 |
Selected Segment Financial Data (unaudited) | |||||||||||||||||||||||||||
(Amounts in millions; percentages of net revenues) | |||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||||||||||||||
Amount | % | Amount | % | Amount | % | Amount | % | ||||||||||||||||||||
Net revenues: | |||||||||||||||||||||||||||
Application Software | $ | 447.9 | $ | 405.4 | $ | 1,251.4 | $ | 1,177.2 | |||||||||||||||||||
430.2 | 391.2 | 1,290.4 | 1,103.7 | ||||||||||||||||||||||||
Measurement & Analytical Solutions | 367.9 | 398.3 | 1,097.0 | 1,208.5 | |||||||||||||||||||||||
Process Technologies | 120.1 | 159.6 | 383.0 | 482.6 | |||||||||||||||||||||||
Total | $ | 1,366.1 | $ | 1,354.5 | $ | 4,021.8 | $ | 3,972.0 | |||||||||||||||||||
Gross profit: | |||||||||||||||||||||||||||
Application Software | $ | 307.6 | 68.7 | % | $ | 275.4 | 67.9 | % | $ | 851.8 | 68.1 | % | $ | 791.5 | 67.2 | % | |||||||||||
287.1 | 66.7 | % | 271.9 | 69.5 | % | 865.1 | 67.0 | % | 763.6 | 69.2 | % | ||||||||||||||||
Measurement & Analytical Solutions | 218.4 | 59.4 | % | 234.7 | 58.9 | % | 654.5 | 59.7 | % | 706.1 | 58.4 | % | |||||||||||||||
Process Technologies | 62.8 | 52.3 | % | 91.6 | 57.4 | % | 205.0 | 53.5 | % | 273.0 | 56.6 | % | |||||||||||||||
Total | $ | 875.9 | 64.1 | % | $ | 873.6 | 64.5 | % | $ | 2,576.4 | 64.1 | % | $ | 2,534.2 | 63.8 | % | |||||||||||
Operating profit*: | |||||||||||||||||||||||||||
Application Software | $ | 125.6 | 28.0 | % | $ | 110.1 | 27.2 | % | $ | 336.6 | 26.9 | % | $ | 299.9 | 25.5 | % | |||||||||||
134.3 | 31.2 | % | 137.5 | 35.1 | % | 403.6 | 31.3 | % | 392.0 | 35.5 | % | ||||||||||||||||
Measurement & Analytical Solutions | 122.5 | 33.3 | % | 127.0 | 31.9 | % | 359.5 | 32.8 | % | 375.4 | 31.1 | % | |||||||||||||||
Process Technologies | 31.5 | 26.2 | % | 55.5 | 34.8 | % | 91.7 | 23.9 | % | 162.8 | 33.7 | % | |||||||||||||||
Total | $ | 413.9 | 30.3 | % | $ | 430.1 | 31.8 | % | $ | 1,191.4 | 29.6 | % | $ | 1,230.1 | 31.0 | % | |||||||||||
*Segment operating profit is before unallocated corporate general and administrative expenses; these expenses were |
Condensed Consolidated Statements of Cash Flows (unaudited) | |||||||||
(Amounts in millions) | |||||||||
Nine months ended | |||||||||
2020 | 2019 | ||||||||
Cash flows from operating activities: | |||||||||
Net earnings | $ | 693.9 | $ | 896.8 | |||||
Adjustments to reconcile net earnings to cash flows from operating activities: | |||||||||
Depreciation and amortization of property, plant and equipment | 38.3 | 35.9 | |||||||
Amortization of intangible assets | 319.8 | 263.2 | |||||||
Amortization of deferred financing costs | 7.4 | 5.2 | |||||||
Non-cash stock compensation | 88.4 | 80.4 | |||||||
Gain on disposal of business, net of associated income tax | — | (87.4 | ) | ||||||
Income tax provision, excluding tax associated with gain on disposal of businesses | 197.9 | 150.4 | |||||||
Changes in operating assets and liabilities, net of acquired businesses: | |||||||||
Accounts receivable | 126.1 | 52.1 | |||||||
Unbilled receivables | (49.1 | ) | (26.6 | ) | |||||
Inventories | (15.2 | ) | (25.2 | ) | |||||
Accounts payable and accrued liabilities | 53.3 | (59.2 | ) | ||||||
Deferred revenue | (57.5 | ) | 26.5 | ||||||
Cash tax paid for gain on disposal of businesses | (201.9 | ) | (39.4 | ) | |||||
Cash income taxes paid, excluding tax associated with gain on disposal of businesses | (236.1 | ) | (255.0 | ) | |||||
Other, net | (14.4 | ) | (22.1 | ) | |||||
Cash provided by operating activities | 950.9 | 995.6 | |||||||
Cash flows from (used in) investing activities: | |||||||||
Acquisitions of businesses, net of cash acquired | (5,653.3 | ) | (2,351.9 | ) | |||||
Capital expenditures | (23.0 | ) | (42.2 | ) | |||||
Capitalized software expenditures | (9.8 | ) | (7.7 | ) | |||||
Proceeds from (used in) disposal of businesses | (4.2 | ) | 220.5 | ||||||
Other, net | (2.7 | ) | (2.5 | ) | |||||
Cash used in investing activities | (5,693.0 | ) | (2,183.8 | ) | |||||
Cash flows from (used in) financing activities: | |||||||||
Proceeds from senior notes | 3,300.0 | 1,200.0 | |||||||
Borrowings (payments) under revolving line of credit, net | 1,160.0 | 60.0 | |||||||
Debt issuance costs | (42.0 | ) | (12.0 | ) | |||||
Cash dividends to stockholders | (160.0 | ) | (143.5 | ) | |||||
Proceeds from stock-based compensation, net | 72.5 | 38.8 | |||||||
7.3 | 5.2 | ||||||||
Other | (1.4 | ) | 3.6 | ||||||
Cash flows from financing activities | 4,336.4 | 1,152.1 | |||||||
Effect of foreign currency exchange rate changes on cash | (1.9 | ) | (5.3 | ) | |||||
Net decrease in cash and cash equivalents | (407.6 | ) | (41.4 | ) | |||||
Cash and cash equivalents, beginning of period | 709.7 | 364.4 | |||||||
Cash and cash equivalents, end of period | $ | 302.1 | $ | 323.0 |
Contact Information:
Investor Relations
941-556-2601
investor-relations@ropertech.com
Source:
2020 GlobeNewswire, Inc., source